Stem cells and neurodegenerative diseases: Where is it all going?

Regenerative Medicine

Volumn 7, Issue 6 SUPPL., 2012, Pages 26-31

  Barker, Roger A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Induced pluripotent stem cells; Neural grafting; Parkinson's disease; Stem cells

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL ELONGATION; CELL POPULATION; CELL PROLIFERATION; DEGENERATIVE DISEASE; DISEASE MODEL; DNA METHYLATION; GENE MUTATION; HUMAN; NERVE REGENERATION; NUCLEAR REPROGRAMMING; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION;

ANIMALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84870701727     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.64     Document Type: Article

References (47)

1. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
2. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
3. Vierbuchen T, Ostermeier A, Pang ZP et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041 (2010).
4. The HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeatexpansion- associated phenotypes. Cell Stem Cell 11(2), 264-278 (2012).
5. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221 (2008).
6. Hu BY, Zhang SC. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc. 4, 1295-1304 (2009).
7. Park IH, Arora N, Huo H et al. Diseasespecific induced pluripotent stem cells. Cell 134, 877-886 (2008).
8. Bilican B, Serio A, Barmada SJ et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc. Natl Acad. Sci. USA 109(15), 5803-5808 (2012).
9. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977 (2009).
10. Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol. Med. 4, 380-395 (2012).
11. Ohi Y, Qin H, Hong C, Blouin L et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 13, 541-549 (2011).
12. Bock C, Kiskinis E, Verstappen G et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
13. Boulting GL, Kiskinis E, Croft GF et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29, 279-286 (2011).
14. Gore A, Li Z, Fung HL, Young JE et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67 (2011).
15. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62 (2011).
16. Soldner F, Laganiere J, Cheng AW et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318-331 (2011).
17. Marion RM, Strati K, Li H, Tejera A et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141-154 (2009).
18. Mathew R, Jia W, Sharma A et al. Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J. 24, 2702-2715 (2010).
19. Suhr ST, Chang EA, Rodriguez RM et al. Telomere dynamics in human cells reprogrammed to pluripotency. PLoS ONE 4, e8124 (2009).
20. Yehezkel S, Rebibo-Sabbah A, Segev Y et al. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 6, 63-75 (2011).
21. Hewitt KJ, Shamis Y, Hayman RB et al. Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. PLoS ONE 6, e17128 (2011).
22. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010).
23. Emdad L, D'Souza SL, Kothari HP et al. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev. 21, 404-410 (2012).
24. Krencik R, Weick JP, Liu Y et al. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat. Biotechnol. 29, 528-534 (2011).
25. Krencik R, Zhang SC. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat. Protoc. 6, 1710-1717 (2011).
26. Thier M, Worsdorfer P, Lakes YB et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 10, 473-479 (2012).
27. Beutner C, Roy K, Linnartz B et al. Generation of microglial cells from mouse embryonic stem cells. Nat. Protoc. 5, 1481-1494 (2010).
28. Pfisterer U, Kirkeby A, Torper O et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl Acad. Sci USA 108, 10343-10348 (2011).
29. Ambasudhan R, Talantova M, Coleman R et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 9, 113-118 (2011).
30. Yoo AS, Sun AX, Li L et al. MicroRNAmediated conversion of human fibroblasts to neurons. Nature 476, 228-231 (2011).
31. Qiang L, Fujita R, Yamashita T et al. Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. Cell 146, 359-371 (2011).
32. Wijeyekoon R, Barker RA. The current status of neural grafting in the treatment of Huntington's disease. A review. Front. Integr. Neurosci. 5, 78 (2011).
33. Brundin P, Barker RA, Parmar M. Neural grafting in Parkinson's Disease. Problems and possibilities. Prog. Brain Res. 184, 265-294 (2010).
34. Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344(10), 710-719 (2001).
35. Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54(3), 403-414 (2003).
36. Politis M, Wu K, Loane C et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2(38), 38ra46 (2010).
37. Sanchez-Danes A, Consiglio A, Richaud Y et al. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum. Gene Ther. 23, 56-69 (2012).
38. Kim H, Lee G, Granat Y et al. miR-371-373 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell 8(6), 695-706 (2011).
39. Roy NS, Cleren C, Singh SK et al. Functional engraftment of human ES cellderived dopaminergic neurons enriched by coculture with telomerase- immortalized midbrain astrocytes. Nat. Med. 12(11), 1259-1268 (2006).
40. Kriks S, Shim JW, Piao J et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551 (2011).
41. Hargus G, Cooper O, Deleidi M et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl Acad. Sci. USA 107, 15921-15926 (2010).
42. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215 (2011).
43. Kim J, Su SC, Wang H et al. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell 9, 413-419 (2011).
44. Liu X, Li F, Stubblefield EA et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 22, 321-332 (2012).
45. Farra N, Zhang WB, Pasceri P et al. Rett syndrome induced pluripotent stem cellderived neurons reveal novel neurophysiological alterations. Mol. Psychiatry doi: 10.1038/mp.2011.180 (2012) (Epub ahead of print).
46. Pedrosa E, Sandler V, Shah A et al. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. J. Neurogenet. 25, 88-103 (2011).
47. DeRosa BA, Van Baaren JM, Dubey GK et al. Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells. Neurosci. Lett. 516, 9-14 (2012).